Robert M Kunemund

Array ( [id] => 9793284 [patent_doc_number] => 20150005228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-01 [patent_title] => 'PEPTIDES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/321624 [patent_app_country] => US [patent_app_date] => 2014-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 25266 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14321624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10806530 [patent_doc_number] => 20160152689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-02 [patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING THROMBOGENESIS' [patent_app_type] => utility [patent_app_number] => 14/901517 [patent_app_country] => US [patent_app_date] => 2014-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 19481 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14901517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11023531 [patent_doc_number] => 20160220486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-04 [patent_title] => 'STABLE LIQUID FORMULATION OF AMG 416 (VELCALCETIDE)' [patent_app_type] => utility [patent_app_number] => 14/908481 [patent_app_country] => US [patent_app_date] => 2014-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 14341 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14908481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10209469 [patent_doc_number] => 20150094457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-02 [patent_title] => 'COMPOSITIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACIDS AND POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 14/290797 [patent_app_country] => US [patent_app_date] => 2014-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 65 [patent_figures_cnt] => 65 [patent_no_of_words] => 130423 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14290797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10906162 [patent_doc_number] => 20140309176 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-16 [patent_title] => 'ETHANOL DEPENDENCE OF ALPHA1 ANTITRYPSIN C-TERMINAL LYS TRUNCATION BY BASIC CARBOXYPEPTIDASES' [patent_app_type] => utility [patent_app_number] => 14/288342 [patent_app_country] => US [patent_app_date] => 2014-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9991 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14288342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10933114 [patent_doc_number] => 20140336134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-13 [patent_title] => 'IAP BIR Domain Binding Compounds' [patent_app_type] => utility [patent_app_number] => 14/285841 [patent_app_country] => US [patent_app_date] => 2014-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 36206 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14285841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12037649 [patent_doc_number] => 09815868 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-11-14 [patent_title] => 'Peptides binding to parallel-stranded G-quadruplexes' [patent_app_type] => utility [patent_app_number] => 14/892087 [patent_app_country] => US [patent_app_date] => 2014-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 6615 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14892087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12112784 [patent_doc_number] => 09868764 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-01-16 [patent_title] => 'Dipeptidyl peptidase-IV (DPPIV), inhibitory peptide compound, composition containing the same, and production method for the same' [patent_app_type] => utility [patent_app_number] => 14/897891 [patent_app_country] => US [patent_app_date] => 2014-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9217 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14897891 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12942616 [patent_doc_number] => 09833497 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-12-05 [patent_title] => Human originated EGF domain proteins and use of the same [patent_app_type] => utility [patent_app_number] => 14/894417 [patent_app_country] => US [patent_app_date] => 2014-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 28 [patent_no_of_words] => 44919 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14894417 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10600243 [patent_doc_number] => 09320791 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-26 [patent_title] => 'Peptides from chaperonin 60.1' [patent_app_type] => utility [patent_app_number] => 14/120259 [patent_app_country] => US [patent_app_date] => 2014-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 3 [patent_no_of_words] => 8836 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14120259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10729601 [patent_doc_number] => 20160075749 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-17 [patent_title] => 'ANTIMICROBIAL PEPTIDE' [patent_app_type] => utility [patent_app_number] => 14/890415 [patent_app_country] => US [patent_app_date] => 2014-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15515 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14890415 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11400458 [patent_doc_number] => 20170020996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-26 [patent_title] => 'ENZYMATIC DEBRIDEMENT THERAPY FOR ABNORMAL CELL PROLIFERATION' [patent_app_type] => utility [patent_app_number] => 14/267395 [patent_app_country] => US [patent_app_date] => 2014-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19100 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14267395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10728316 [patent_doc_number] => 20160074464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-17 [patent_title] => 'ANGIOTENSINS IN MUSCULAR DYSTROPHY' [patent_app_type] => utility [patent_app_number] => 14/785538 [patent_app_country] => US [patent_app_date] => 2014-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 24688 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14785538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10559542 [patent_doc_number] => 09283193 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-15 [patent_title] => 'Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents' [patent_app_type] => utility [patent_app_number] => 14/249621 [patent_app_country] => US [patent_app_date] => 2014-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 17 [patent_no_of_words] => 8915 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14249621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12302721 [patent_doc_number] => 09937265 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-04-10 [patent_title] => Self-assembling peptide and polysaccharide complexes [patent_app_type] => utility [patent_app_number] => 14/782961 [patent_app_country] => US [patent_app_date] => 2014-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 17 [patent_no_of_words] => 12137 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14782961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10997434 [patent_doc_number] => 20160194380 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-07 [patent_title] => 'POTENT INHIBITORS OF HUMAN MATRIPTASE DERIVED FROM MCOTI-II VARIANTS' [patent_app_type] => utility [patent_app_number] => 14/783569 [patent_app_country] => US [patent_app_date] => 2014-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12368 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14783569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10149025 [patent_doc_number] => 09181300 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-10 [patent_title] => 'Polypeptides for treating and/or limiting influenza infection' [patent_app_type] => utility [patent_app_number] => 14/221346 [patent_app_country] => US [patent_app_date] => 2014-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 11 [patent_no_of_words] => 26481 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 291 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14221346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10693727 [patent_doc_number] => 20160039873 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-11 [patent_title] => 'PEPTIDES WITH ANTIFUNGAL ACTIVITY AND METHODS OF USING THE PEPTIDES' [patent_app_type] => utility [patent_app_number] => 14/777321 [patent_app_country] => US [patent_app_date] => 2014-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8981 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14777321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11561700 [patent_doc_number] => 09624272 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-18 [patent_title] => 'Polypeptides for treating and/or limiting influenza infection' [patent_app_type] => utility [patent_app_number] => 14/766375 [patent_app_country] => US [patent_app_date] => 2014-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 13836 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14766375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11642206 [patent_doc_number] => 09663562 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-30 [patent_title] => 'Compositions and methods for treating cancer' [patent_app_type] => utility [patent_app_number] => 14/776379 [patent_app_country] => US [patent_app_date] => 2014-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12120 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14776379 [rel_patent_id] =>[rel_patent_doc_number] =>)